Tirzepatide May Reduce Diabetic Retinopathy Risk in Patients With Diabetes
Episode Summary
Tirzepatide’s weight-loss benefits may also lower diabetic retinopathy risk through improved metabolic control, potentially influencing diabetes management strategies for overweight patients at risk of eye complications.